Skip to main content
Premium Trial:

Request an Annual Quote

Monsanto Licenses CRISPR From Broad Institute for Ag-Bio Applications

NEW YORK (GenomeWeb) – Monsanto announced today that it has obtained a global, non-exclusive licensing agreement from the Broad Institute for agricultural applications of CRISPR genome editing technology.

CRISPR-based genome editing offers "site-directed integration of specific genes as well as the opportunity to enhance beneficial [plant characteristics] or remove undesired plant characteristics," Monsanto said in a statement.

"The license to CRISPR/Cas from the Broad Institute provides access to an exciting tool for our growing body of genome-editing research," Monsanto biotechnology lead Tom Adams added. "Genome-editing technology is complementary to our ongoing discovery research and provides an incredible resource to further unlock our world-leading germplasm and genome libraries."

Financial and other terms of the agreement were not disclosed.

Monsanto joins DuPont Pioneer and Calyxt in pursuing CRISPR/Cas9 for ag-bio applications. DuPont Pioneer has cross-licensed CRISPR/Cas9 technology with CRISPR technology firm Caribou Biosciences, and has licensed Cas9 technology from Lithuania's Vilnius University. Calyxt, a subsidiary of Cellectis, has licensed patents covering the use of CRISPR/Cas9 in plants from the University of Minnesota.

Last week, German pharmaceutical company Bayer announced plans for a $66 billion merger with Monsanto. Bayer's Crop Science division has partnered on plant genome-editing with Cellectis, but has not licensed any CRISPR/Cas9 technology. However, Bayer's Life Science Center has licensed CRISPR/Cas9 for certain biomedical applications.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.